Author:
Giannopoulos K,Mertens D,Bühler A,Barth T F E,Idler I,Möller P,Kröber A,Greiner J,Chocholska S,Dmoszyñska A,Roliñski J,Döhner H,Stilgenbauer S,Schmitt M
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference24 articles.
1. Montserrat E . New prognostic markers in CLL. Hematol Am Soc Hematol Educ Program 2006, 279–284.
2. Greiner J, Li L, Ringhoffer M, Barth TF, Giannopoulos K, Guillaume P et al. Identification and characterization of epitopes of the receptor for hyaluronic acid mediated motility (RHAMM/CD168) recognized by CD8 positive T cells of HLA-A2 positive patients with acute myeloid leukemia. Blood 2005; 106: 938–945.
3. Schmitt M, Li L, Giannopoulos K, Chen J, Brunner C, Barth T et al. Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules. Exp Hematol 2006; 34: 1709–1719.
4. Giannopoulos K, Li L, Bojarska-Junak A, Rolinski J, Dmoszynska A, Hus I et al. Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia. Int J Oncol 2006; 29: 95–103.
5. Crainie M, Belch AR, Mant MJ, Pilarski L . Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clones in multiple myeloma: identification of three distinct RHAMM variants. Blood 1999; 93: 1684–1696.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献